跳至主要内容
临床试验/NCT07285226
NCT07285226招募中不适用

Impact of 12-Week Creatine HCl Supplementation on Body Composition, Functional Muscle and Brain Performance, Blood Biomarkers, and Tissue Creatine Levels in Older Adults With Sarcopenia

Center for Health Sciences, Serbia2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
2
主要终点
Hand-grip strength

研究概览

简要总结

The CONCRET-SARCOPA trial is a 12-week, double-blind, randomized controlled study designed to evaluate the efficacy of creatine HCl supplementation in older adults with sarcopenia. The trial investigates whether daily creatine HCl improves body composition, enhances functional muscle and cognitive performance, and favorably alters key blood biomarkers associated with muscle health and metabolic status. Additionally, the study assesses changes in tissue creatine levels using non-invasive and biochemical methods to clarify mechanistic responses to supplementation. Findings from this trial will provide critical evidence on the therapeutic potential of creatine HCl as a targeted nutritional strategy for managing sarcopenia in the geriatric population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 60 years
  • Low muscle strength by handgrip (SDOC criteria for sarcopenia): < 35.5 kg in men and < 20 kg in women
  • Sign free and informed consent
  • Demonstrate interest, conditions and availability to participate

排除标准

  • Patients undergoing interventional treatment for sarcopenia
  • Physical amputation
  • Cognitive impairment (MSSE < 25)
  • Unwillingness to return for follow-up analysis
  • Participation in other clinical trials

结局指标

主要结局

Hand-grip strength

时间窗: Change from baseline hand-grip strength at 12 weeks

Handgrip strength quantifies maximal voluntary force generated by the hand using a dynamometer, serving as a simple, reliable indicator of overall muscle function and sarcopenia severity.

次要结局

  • Senior fitness test score(Change from baseline senior fitness test score at 12 weeks)
  • Mini-Mental State Examination Score(Change from baseline Mini-Mental State Examination Score at 12 weeks)
  • Appendicular muscle mass(Change from baseline appendicular muscle mass at 12 weeks)
  • Irisin(Change from baseline serum levels of irisin at 12 weeks)
  • Brain creatine(Change from baseline brain creatine concentrations at 12 weeks)

研究者

发起方
Center for Health Sciences, Serbia
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验